News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
266,589 Results
Type
Article (14189)
Company Profile (283)
Press Release (252117)
Section
Business (79554)
Career Advice (153)
Deals (13233)
Drug Delivery (35)
Drug Development (50443)
Employer Resources (31)
FDA (5717)
Job Trends (5143)
News (144457)
Policy (10031)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (911)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21646)
ALS (60)
Alzheimer's disease (824)
Antibody-drug conjugate (ADC) (86)
Approvals (5732)
Artificial intelligence (107)
Autoimmune disease (10)
Automation (5)
Bankruptcy (104)
Best Places to Work (4573)
BIOSECURE Act (5)
Biosimilars (39)
Biotechnology (233)
Bladder cancer (43)
Brain cancer (19)
Breast cancer (139)
Cancer (1281)
Cardiovascular disease (100)
Career advice (132)
Career pathing (2)
CAR-T (107)
Cell therapy (304)
Cervical cancer (7)
Clinical research (40855)
Collaboration (495)
Compensation (218)
Complete response letters (13)
COVID-19 (1034)
CRISPR (36)
C-suite (141)
Cystic fibrosis (76)
Data (1333)
Denatured (11)
Depression (28)
Diabetes (122)
Diagnostics (1294)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (76)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (81)
Earnings (29646)
Editorial (17)
Employer branding (4)
Employer resources (29)
Events (48116)
Executive appointments (396)
FDA (6329)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (462)
Gene editing (87)
Generative AI (9)
Gene therapy (226)
GLP-1 (353)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6593)
Huntington's disease (21)
IgA nephropathy (20)
Immunology and inflammation (78)
Indications (18)
Infectious disease (1097)
Inflammatory bowel disease (110)
Inflation Reduction Act (8)
Influenza (18)
Intellectual property (55)
Interviews (17)
IPO (7264)
IRA (11)
Job creations (863)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (200)
Leadership (2)
Legal (1386)
Liver cancer (30)
Lung cancer (185)
Lymphoma (81)
Machine learning (1)
Management (7)
Manufacturing (114)
MASH (47)
Medical device (2592)
Medtech (2593)
Mergers & acquisitions (6256)
Metabolic disorders (359)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (57)
Neuropsychiatric disorders (23)
Neuroscience (1187)
NextGen: Class of 2025 (2020)
Non-profit (858)
Northern California (1531)
Now hiring (21)
Obesity (184)
Opinion (100)
Ovarian cancer (59)
Pain (40)
Pancreatic cancer (51)
Parkinson's disease (104)
Partnered (6)
Patents (109)
Patient recruitment (66)
Peanut (35)
People (25503)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14421)
Phase II (19008)
Phase III (12017)
Pipeline (680)
Podcasts (46)
Policy (35)
Postmarket research (852)
Preclinical (6059)
Press Release (30)
Prostate cancer (52)
Psychedelics (35)
Radiopharmaceuticals (211)
Rare diseases (270)
Real estate (1418)
Recruiting (12)
Regulatory (8551)
Reports (15)
Research institute (936)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (91)
Series B (59)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1357)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1971)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (33)
United States (11978)
Vaccines (204)
Venture capitalists (28)
Webinars (7)
Weight loss (105)
Women's health (15)
Worklife (2)
Date
Today (10)
Last 7 days (360)
Last 30 days (1520)
Last 365 days (19950)
2025 (4562)
2024 (20558)
2023 (22418)
2022 (26834)
2021 (27813)
2020 (23381)
2019 (16265)
2018 (11759)
2017 (13754)
2016 (11847)
2015 (14353)
2014 (10401)
2013 (7488)
2012 (7537)
2011 (7619)
2010 (7431)
Location
Africa (148)
Alabama (38)
Alaska (2)
Arizona (52)
Arkansas (5)
Asia (17213)
Australia (2916)
California (3482)
Canada (1044)
China (319)
Colorado (135)
Connecticut (143)
Delaware (88)
Europe (37028)
Florida (408)
Georgia (106)
Idaho (17)
Illinois (209)
India (8)
Indiana (85)
Iowa (1)
Japan (68)
Kansas (59)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (442)
Massachusetts (2738)
Michigan (69)
Minnesota (134)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (15)
New Hampshire (14)
New Jersey (871)
New Mexico (12)
New York (949)
North Carolina (517)
North Dakota (4)
Northern California (1531)
Ohio (107)
Oklahoma (9)
Oregon (21)
Pennsylvania (663)
Puerto Rico (3)
Rhode Island (15)
South America (208)
South Carolina (4)
Southern California (1357)
Tennessee (25)
Texas (397)
Utah (48)
Virginia (67)
Washington D.C. (28)
Washington State (316)
Wisconsin (13)
266,589 Results for "orchard therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orchard Therapeutics Announces Reimbursement Agreement in Spain
February 28, 2025
·
4 min read
Press Releases
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
February 3, 2025
·
14 min read
Press Releases
Orchard Therapeutics Appoints Robin Kenselaar to Chief Commercial Officer and Announces Multiple Business Updates Pertaining to its Approved HSC Gene Therapy for MLD
February 12, 2025
·
14 min read
Press Releases
Orchard Therapeutics Announces Multiple Data Presentations and Publications
October 24, 2024
·
7 min read
Genetown
Orchard Therapeutics Celebrates Global Progress toward Advancing Newborn Screening for MLD on International Neonatal Screening Day
Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, announced a number of updates pertaining to the advancement of universal newborn screening for metachromatic leukodystrophy.
June 28, 2024
·
10 min read
Genetown
Orchard Therapeutics Announces Multiple Presentations at ASGCT 2024
Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, announced four oral and four poster presentations from across its hematopoietic stem cell gene therapy platform will be featured at the 27th Annual Meeting of the American Society of Gene and Cell Therapy taking place May 7-11, 2024, in Baltimore.
May 7, 2024
·
11 min read
Deals
Kyowa Kirin to Acquire Orchard Therapeutics
Kyowa Kirin Co., Ltd. and Orchard Therapeutics plc announced the companies have entered into a definitive agreement under which Kyowa Kirin will acquire Orchard Therapeutics for $16.00 per American Depositary Share in cash, under which Orchard shareholders will hold an additional contingent value right of $1.00 per ADS.
October 5, 2023
·
19 min read
Deals
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
Kyowa Kirin Co., Ltd. a Japan-based global specialty pharmaceutical company discovering and developing novel medicines utilizing the latest biotechnology, and Orchard Therapeutics plc, a global gene therapy leader, announced Kyowa Kirin has successfully completed the acquisition of Orchard Therapeutics.
January 24, 2024
·
9 min read
Genetown
Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLD Symposium
Orchard Therapeutics today announced 10 presentations from across its neurometabolic portfolio will be featured at the 20th Annual WORLD Symposium™ taking place February 4-9, 2024, in San Diego, California.
February 2, 2024
·
5 min read
Genetown
Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Orchard Therapeutics today announced the details of its U.S. commercial launch of Lenmeldy™ (atidarsagene autotemcel), formerly known as OTL-200.
March 20, 2024
·
17 min read
1 of 26,659
Next